Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246090
Status:
COMPLETED
Last Update Posted:
2014-07-14
First Post:
2005-10-27
Brief Title:
A Phase II Study of E7389 in Patients With Breast Cancer Previously Treated With Anthracycline Taxane and Capecitabine
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
E7389-G000-211
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eisai Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Eisai Medical Services
Old Organization:
Eisai Inc
Collaborators
| Name | Class |
|---|---|
| Eisai Limited | INDUSTRY |